• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

最近流行的 SARS-CoV-2 奥密克戎 BA.2.86、JN.1、EG.5、EG.5.1 和 HV.1 亚变体的刺突结构、受体结合和免疫逃逸。

Spike structures, receptor binding, and immune escape of recently circulating SARS-CoV-2 Omicron BA.2.86, JN.1, EG.5, EG.5.1, and HV.1 sub-variants.

机构信息

CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, China; Beijing Life Science Academy, Beijing, China.

CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, China; Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area of China, College of Life Sciences, South-Central Minzu University, Wuhan, China.

出版信息

Structure. 2024 Aug 8;32(8):1055-1067.e6. doi: 10.1016/j.str.2024.06.012. Epub 2024 Jul 15.

DOI:10.1016/j.str.2024.06.012
PMID:
39013463
Abstract

The recently emerged BA.2.86, JN.1, EG.5, EG.5.1, and HV.1 variants have a growth advantage. In this study, we explore the structural bases of receptor binding and immune evasion for the Omicron BA.2.86, JN.1, EG.5, EG.5.1, and HV.1 sub-variants. Our findings reveal that BA.2.86 exhibits strong receptor binding, whereas its JN.1 sub-lineage displays a decreased binding affinity to human ACE2 (hACE2). Through complex structure analyses, we observed that the reversion of R493Q in BA.2.86 receptor binding domain (RBD) plays a facilitating role in receptor binding, while the L455S substitution in JN.1 RBD restores optimal affinity. Furthermore, the structure of monoclonal antibody (mAb) S309 complexed with BA.2.86 RBD highlights the importance of the K356T mutation, which brings a new N-glycosylation motif, altering the binding pattern of mAbs belonging to RBD-5 represented by S309. These findings emphasize the importance of closely monitoring BA.2.86 and its sub-lineages to prevent another wave of SARS-CoV-2 infections.

摘要

最近出现的 BA.2.86、JN.1、EG.5、EG.5.1 和 HV.1 变体具有生长优势。在这项研究中,我们探索了奥密克戎 BA.2.86、JN.1、EG.5、EG.5.1 和 HV.1 亚变体的受体结合和免疫逃逸的结构基础。我们的研究结果表明,BA.2.86 表现出强烈的受体结合能力,而其 JN.1 亚谱系对人类 ACE2(hACE2)的结合亲和力降低。通过复杂的结构分析,我们观察到 BA.2.86 受体结合域(RBD)中 R493Q 的回复在受体结合中发挥促进作用,而 JN.1 RBD 中的 L455S 取代恢复了最佳亲和力。此外,与 BA.2.86 RBD 结合的单克隆抗体(mAb)S309 的结构强调了 K356T 突变的重要性,该突变带来了新的 N-糖基化基序,改变了 S309 代表的 RBD-5 类 mAb 的结合模式。这些发现强调了密切监测 BA.2.86 及其亚谱系以防止 SARS-CoV-2 感染再次出现的重要性。

相似文献

1
Spike structures, receptor binding, and immune escape of recently circulating SARS-CoV-2 Omicron BA.2.86, JN.1, EG.5, EG.5.1, and HV.1 sub-variants.最近流行的 SARS-CoV-2 奥密克戎 BA.2.86、JN.1、EG.5、EG.5.1 和 HV.1 亚变体的刺突结构、受体结合和免疫逃逸。
Structure. 2024 Aug 8;32(8):1055-1067.e6. doi: 10.1016/j.str.2024.06.012. Epub 2024 Jul 15.
2
Integrative Computational Modeling of Distinct Binding Mechanisms for Broadly Neutralizing Antibodies Targeting SARS-CoV-2 Spike Omicron Variants: Balance of Evolutionary and Dynamic Adaptability in Shaping Molecular Determinants of Immune Escape.针对新冠病毒刺突奥密克戎变体的广泛中和抗体不同结合机制的整合计算建模:免疫逃逸分子决定因素形成过程中进化与动态适应性的平衡
Viruses. 2025 May 22;17(6):741. doi: 10.3390/v17060741.
3
An mRNA vaccine encoding the SARS-CoV-2 Omicron XBB.1.5 receptor-binding domain protects mice from the JN.1 variant.一种编码严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎XBB.1.5受体结合结构域的信使核糖核酸(mRNA)疫苗可保护小鼠免受JN.1变体的感染。
EBioMedicine. 2025 Jun 6;117:105794. doi: 10.1016/j.ebiom.2025.105794.
4
AlphaFold2 Modeling and Molecular Dynamics Simulations of the Conformational Ensembles for the SARS-CoV-2 Spike Omicron JN.1, KP.2 and KP.3 Variants: Mutational Profiling of Binding Energetics Reveals Epistatic Drivers of the ACE2 Affinity and Escape Hotspots of Antibody Resistance.AlphaFold2 对 SARS-CoV-2 刺突奥密克戎 JN.1、KP.2 和 KP.3 变体构象集合的建模和分子动力学模拟:结合能突变分析揭示 ACE2 亲和力的上位驱动因素和抗体耐药性逃逸热点。
Viruses. 2024 Sep 13;16(9):1458. doi: 10.3390/v16091458.
5
Structural basis for the evolution and antibody evasion of SARS-CoV-2 BA.2.86 and JN.1 subvariants.SARS-CoV-2 BA.2.86 和 JN.1 亚变种的进化和抗体逃逸的结构基础。
Nat Commun. 2024 Sep 4;15(1):7715. doi: 10.1038/s41467-024-51973-8.
6
Allostery Links hACE2 Binding, Pan-variant Neutralization and Helical Extension in the SARS-CoV-2 Spike Protein.别构效应将严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白中的人血管紧张素转换酶2(hACE2)结合、全变体中和及螺旋延伸联系起来。
J Mol Biol. 2025 Sep 1;437(17):169232. doi: 10.1016/j.jmb.2025.169232. Epub 2025 May 28.
7
The ACE2 decoy receptor can overcome immune escape by rapid mutating SARS-CoV-2 variants and reduce cytokine induction and clot formation.血管紧张素转换酶2(ACE2)诱饵受体可以通过快速突变的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体克服免疫逃逸,并减少细胞因子诱导和血栓形成。
J Biomed Sci. 2025 Jun 26;32(1):59. doi: 10.1186/s12929-025-01156-4.
8
Neutralization of EG.5, EG.5.1, BA.2.86, and JN.1 by antisera from dimeric receptor-binding domain subunit vaccines and 41 human monoclonal antibodies.二聚体受体结合域亚单位疫苗和 41 个人源单克隆抗体对 EG.5、EG.5.1、BA.2.86 和 JN.1 的中和作用。
Med. 2024 May 10;5(5):401-413.e4. doi: 10.1016/j.medj.2024.03.006. Epub 2024 Apr 3.
9
A multispecific antibody against SARS-CoV-2 prevents immune escape in vitro and confers prophylactic protection in vivo.一种针对 SARS-CoV-2 的多特异性抗体可防止体外免疫逃逸,并在体内提供预防保护。
Sci Transl Med. 2024 Oct 9;16(768):eado9026. doi: 10.1126/scitranslmed.ado9026.
10
Comparative analysis of replication and immune evasion among SARS-CoV-2 subvariants BA.2.86, JN.1, KP.2, and KP.3.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)亚型BA.2.86、JN.1、KP.2和KP.3的复制与免疫逃逸比较分析
mBio. 2025 Apr 29:e0350324. doi: 10.1128/mbio.03503-24.

引用本文的文献

1
From immune evasion to broad binding: computational optimization of SARS-CoV-2 RBD-targeting nanobody.从免疫逃逸到广泛结合:针对严重急性呼吸综合征冠状病毒2受体结合域的纳米抗体的计算优化
Front Immunol. 2025 Aug 14;16:1637955. doi: 10.3389/fimmu.2025.1637955. eCollection 2025.
2
Characterization of private mutations in the spike protein of SARS-CoV-2 correlates with viral prevalence.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白中私有突变的特征与病毒流行率相关。
BMC Infect Dis. 2025 Aug 8;25(1):996. doi: 10.1186/s12879-025-11414-3.
3
Optimizing the breadth of SARS-CoV-2-neutralizing antibodies in vivo and in silico.
在体内和计算机模拟中优化新冠病毒中和抗体的广度
Hum Vaccin Immunother. 2025 Dec;21(1):2526873. doi: 10.1080/21645515.2025.2526873. Epub 2025 Jul 21.
4
Structural and functional insights into the evolution of SARS-CoV-2 KP.3.1.1 spike protein.对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)KP.3.1.1刺突蛋白进化的结构和功能见解。
Cell Rep. 2025 Jul 4;44(7):115941. doi: 10.1016/j.celrep.2025.115941.
5
Evolutionary dynamics of heparan sulfate utilization by SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)对硫酸乙酰肝素的利用的进化动力学
mBio. 2025 Jun 23:e0130325. doi: 10.1128/mbio.01303-25.
6
Comparative analysis of replication and immune evasion among SARS-CoV-2 subvariants BA.2.86, JN.1, KP.2, and KP.3.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)亚型BA.2.86、JN.1、KP.2和KP.3的复制与免疫逃逸比较分析
mBio. 2025 Apr 29:e0350324. doi: 10.1128/mbio.03503-24.
7
Molecular Basis of High-Blood-Pressure-Enhanced and High-Fever-Temperature-Weakened Receptor-Binding Domain/Peptidase Domain Binding: A Molecular Dynamics Simulation Study.高血压增强和高热削弱的受体结合域/肽酶结构域结合的分子基础:一项分子动力学模拟研究
Int J Mol Sci. 2025 Mar 31;26(7):3250. doi: 10.3390/ijms26073250.
8
Increased preference for lysine over arginine in spike proteins of SARS-CoV-2 BA.2.86 variant and its daughter lineages.在新冠病毒BA.2.86变体及其子代谱系的刺突蛋白中,赖氨酸相对于精氨酸的偏好增加。
PLoS One. 2025 Apr 7;20(4):e0320891. doi: 10.1371/journal.pone.0320891. eCollection 2025.
9
Regional dynamics and mechanisms behind SARS-CoV-2 XDV.1 prevalence in Chongqing via genomic surveillance and molecular insights.通过基因组监测和分子洞察揭示重庆地区新冠病毒XDV.1毒株流行背后的区域动态及机制
Virus Res. 2025 May;355:199562. doi: 10.1016/j.virusres.2025.199562. Epub 2025 Mar 24.
10
Mutational Scanning and Binding Free Energy Computations of the SARS-CoV-2 Spike Complexes with Distinct Groups of Neutralizing Antibodies: Energetic Drivers of Convergent Evolution of Binding Affinity and Immune Escape Hotspots.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白复合物与不同组中和抗体的突变扫描及结合自由能计算:结合亲和力趋同进化和免疫逃逸热点的能量驱动因素
Int J Mol Sci. 2025 Feb 11;26(4):1507. doi: 10.3390/ijms26041507.